Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

SLDB

Solid Biosciences Inc

Jul 26 • 04:00PM ET

9.29

Dollar change +0.24
Percentage change 2.65	%

Healthcare • Biotechnology • USA • NASD

Stock Detail • Compare Perf. • Financials • Options Chain • Save to Portfolio • Create Alert

Held by: IWM VTI VXF IWN VTWO IWC FESM AVSC IWO DFAS

Scroll to Statements

Index	RUT	P/E	-	EPS (ttm)	-3.93	Insider Own	17.24%	Shs Outstand	38.38M	Perf Week	13.02%
Market Cap	356.55M	Forward P/E	-	EPS next Y	-2.77	Insider Trans	0.01%	Shs Float	31.76M	Perf Month	62.98%
Income	-90.25M	PEG	-	EPS next Q	-0.65	Inst Own	78.08%	Short Float	5.22%	Perf Quarter	8.78%
Sales	0.00M	P/S	-	EPS this Y	43.56%	Inst Trans	-0.60%	Short Ratio	3.59	Perf Half Y	14.69%
Book/sh	5.57	P/B	1.67	EPS next Y	-1.56%	ROA	-37.74%	Short Interest	1.66M	Perf Year	104.63%
Cash/sh	5.37	P/C	1.73	EPS next 5Y	-	ROE	-45.75%	52W Range	1.81 - 15.05	Perf YTD	51.30%
Dividend Est.	-	P/FCF	-	EPS past 5Y	32.21%	ROI	-38.51%	52W High	-38.27%	Beta	1.76
Dividend TTM	-	Quick Ratio	14.94	Sales past 5Y	-28.11%	Gross Margin	-	52W Low	413.26%	ATR (14)	0.79
Dividend Ex-Date	-	Current Ratio	14.94	EPS Y/Y TTM	52.93%	Oper. Margin	0.00%	RSI (14)	60.72	Volatility	6.92% 10.23%
Employees	88	Debt/Eq	0.12	Sales Y/Y TTM	-100.00%	Profit Margin	-	Recom	1.11	Target Price	18.57
Option/Short	Yes / Yes	LT Debt/Eq	0.11	EPS Q/Q	58.55%	Payout	-	Rel Volume	0.54	Prev Close	9.05
Sales Surprise	-100.00%	EPS Surprise	0.03%	Sales Q/Q	-	Earnings	May 09	Avg Volume	461.63K	Price	9.29
SMA20	23.09%	SMA50	20.35%	SMA200	26.91%	Trades		Volume	250,951	Change	2.65%

Date	Action	Analyst	Rating Change	Price Target Change
Jul-15-24	Upgrade	JP Morgan	Neutral → Overweight	$10 → $15
Jun-24-24	Upgrade	Leerink Partners	Market Perform → Outperform	$12
May-31-24	Resumed	Piper Sandler	Overweight	$20
Mar-28-24	Initiated	William Blair	Outperform	$40
Mar-15-24	Initiated	Citigroup	Buy	$16
Mar-14-24	Upgrade	Piper Sandler	Neutral → Overweight	$8 → $20
Dec-08-23	Initiated	H.C. Wainwright	Buy	$9
Jul-12-21	Initiated	Piper Sandler	Neutral	$6
May-27-21	Initiated	Jefferies	Buy	$7
Mar-16-21	Upgrade	SVB Leerink	Mkt Perform → Outperform	$3 → $15
Mar-09-21	Initiated	Barclays	Overweight	$13
Jan-08-21	Upgrade	Credit Suisse	Underperform → Neutral	$2 → $7
Jul-28-20	Downgrade	SVB Leerink	Outperform → Mkt Perform
May-07-20	Downgrade	Evercore ISI	Outperform → In-line
Oct-11-19	Initiated	Evercore ISI	Outperform	$22
Aug-29-19	Downgrade	Citigroup	Neutral → Sell	$6
Aug-19-19	Upgrade	SVB Leerink	Mkt Perform → Outperform	$8 → $15
Aug-16-19	Upgrade	Chardan Capital Markets	Neutral → Buy	$7.50 → $10
May-14-19	Downgrade	Goldman	Neutral → Sell	$5 → $4
May-14-19	Downgrade	Credit Suisse	Neutral → Underperform	$7 → $6

Show Previous Ratings

Jul-01-24 04:19PM	Solid Biosciences Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) (GlobeNewswire) +10.58%
08:00AM	Solid Biosciences Joins the Russell 3000 Index (GlobeNewswire)
Jun-21-24 07:52AM	Today's Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Friday (InvestorPlace)
Jun-04-24 04:00PM	Solid Biosciences Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) (GlobeNewswire)
May-20-24 06:00AM	3 Must-Buy Biotech Stocks Before the Summer Rally Kicks Off (InvestorPlace)
12:53PM	Loading…
May-15-24 12:53PM	SLDB Stock Earnings: Solid Biosciences Meets EPS for Q1 2024 (InvestorPlace)
07:52AM	Solid Biosciences Provides First Quarter 2024 Business Update and Financial Results (GlobeNewswire)
May-07-24 07:00AM	Solid Biosciences to Present at the American Society of Gene and Cell Therapy Annual Meeting (GlobeNewswire)
May-02-24 04:05PM	Solid Biosciences Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) (GlobeNewswire) +7.23%
Apr-03-24 04:05PM	Solid Biosciences Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) (GlobeNewswire)
Apr-02-24 10:35AM	Solid Biosciences (SLDB) Falls Despite FDA Rare Tag for DMD Drug (Zacks)
07:20AM	Solid Biosciences' SGT-003 receives rare pediatric disease designation (Pharmaceutical Business Review)
Apr-01-24 07:45AM	Solid Biosciences Receives Rare Pediatric Disease Designation from the FDA for Duchenne Muscular Dystrophy Gene Therapy Candidate SGT-003 (GlobeNewswire) -6.61%
Mar-28-24 04:08PM	How Sleeper Biotech Solid Biosciences, With A 687% Gain, Is Making A Comeback (Investor's Business Daily) -6.53%
Mar-27-24 07:00AM	Solid Biosciences to Participate at Cantor's Virtual Muscular Dystrophy Symposium (GlobeNewswire) +5.01%
07:44AM	Loading…
Mar-13-24 07:44AM	Solid Biosciences Provides Fourth Quarter and Full-Year 2023 Business Update and Financial Results (GlobeNewswire) +7.28%
Mar-07-24 07:00AM	Solid Biosciences Announces Licensing Agreement with Armatus Bio for the Use of AAV-SLB101, a Proprietary, Muscle-Targeted Capsid, in the Development of an RNAi Therapy to treat FSHD (GlobeNewswire) +7.86%
Mar-06-24 08:00AM	Solid Biosciences to Participate at Upcoming Investor Conferences (GlobeNewswire)
Feb-29-24 03:02AM	14 Stocks With Heavy Insider Buying In 2024 (Insider Monkey)
Jan-17-24 11:27AM	Solid Biosciences' (SLDB) DMD Drug Gets Orphan Tag, Stock Up (Zacks)
Jan-16-24 01:10PM	Hedge Fund and Insider Trading News: Anthony Scaramucci, Bill Ackman, Rokos Capital Management, ExodusPoint Capital, Alden Global Capital, Solid Biosciences Inc. (SLDB), and More (Insider Monkey)
08:00AM	Solid Biosciences Granted FDA Orphan Drug Designation for Duchenne Muscular Dystrophy Gene Therapy Candidate SGT-003 (GlobeNewswire)
Jan-15-24 10:18AM	Solid Biosciences (SLDB) Rises 271% in 3 Months: Here's Why (Zacks)
Jan-08-24 07:09AM	Solid Biosciences Announces $109 Million Private Placement (GlobeNewswire) +7.59%
Jan-04-24 08:00AM	Solid Biosciences to Participate at 42nd Annual J.P. Morgan Healthcare Conference (GlobeNewswire)
Dec-08-23 05:37AM	Solid Biosciences' (SLDB) DMD Drug Gets Fast Track Tag, Stock Up (Zacks) -12.15%
Dec-07-23 08:00AM	Solid Biosciences Receives FDA Fast Track Designation for Duchenne Muscular Dystrophy Gene Therapy SGT-003 (GlobeNewswire) +68.42%
Nov-22-23 08:00AM	Solid Biosciences to Participate at 35th Annual Piper Sandler Healthcare Conference (GlobeNewswire) +9.17%
Nov-16-23 08:29AM	Solid Biosciences (SLDB) Stock Up as FDA Clears DMD Drug IND (Zacks)
Nov-14-23 04:05PM	Solid Biosciences Announces IND Clearance by FDA for Duchenne Muscular Dystrophy Gene Therapy Candidate SGT-003 (GlobeNewswire) +27.93%
08:00AM	Loading…
Nov-09-23 08:00AM	Solid Biosciences to Participate at Jefferies London Healthcare Conference (GlobeNewswire) -23.66%
Nov-08-23 04:17PM	Solid Biosciences Provides Third Quarter Business Update and Financial Results (GlobeNewswire)
Oct-02-23 08:00AM	Solid Biosciences Appoints Gabriel Brooks, M.D., as Chief Medical Officer (GlobeNewswire)
Sep-20-23 08:00AM	Solid Biosciences to Participate at Upcoming Investor Conferences (GlobeNewswire)
Sep-05-23 08:56AM	Solid Biosciences to Participate at Upcoming Investor Conferences (GlobeNewswire)
Aug-31-23 08:00AM	Solid Biosciences to Participate in Citis 18th Annual BioPharma Conference (GlobeNewswire)
Aug-14-23 04:17PM	Solid Biosciences Provides Second Quarter Business Update and Financial Results (GlobeNewswire)
Jun-01-23 08:00AM	Solid Biosciences to Participate at the Jefferies Healthcare Conference (GlobeNewswire)
May-22-23 08:00AM	Solid Biosciences to Participate at the Barclays Gene Editing & Therapy Summit (GlobeNewswire)
May-16-23 08:00AM	Solid Biosciences to Present at the American Society of Gene and Cell Therapy Annual Meeting (GlobeNewswire)
May-11-23 09:35AM	Solid Biosciences Inc. (SLDB) Reports Q1 Loss, Misses Revenue Estimates (Zacks)
07:30AM	Solid Biosciences Provides First Quarter Business Update and Financial Results (GlobeNewswire)
May-08-23 04:05PM	Solid Biosciences to Present at JMP Securities Life Sciences Conference (GlobeNewswire) +9.80%
Apr-21-23 08:00AM	Solid Biosciences to Participate in Chardans 7th Annual Genetic Medicines and Cell Therapy Manufacturing Summit (GlobeNewswire)
Apr-20-23 10:03AM	Will Alnylam Pharmaceuticals (ALNY) Report Negative Q1 Earnings? What You Should Know (Zacks)
Apr-19-23 10:01AM	Will Solid Biosciences Inc. (SLDB) Report Negative Q1 Earnings? What You Should Know (Zacks)
Apr-13-23 08:00AM	Solid Biosciences to Present at the 22nd Annual Needham Healthcare Conference (GlobeNewswire)
Mar-25-23 09:44AM	Solid Biosciences Full Year 2022 Earnings: EPS Misses Expectations (Simply Wall St.)
Mar-23-23 08:00AM	Solid Biosciences Provides Fourth Quarter and Full-Year 2022 Business Update and Financial Results (GlobeNewswire)
Mar-21-23 08:00AM	Solid Biosciences to Participate at BMO Biopharma Spotlight Series: Genetic Medicine Delivery (GlobeNewswire)
Mar-07-23 08:00AM	Solid Biosciences to Present at Barclays Global Healthcare Conference (GlobeNewswire) +5.01%
Mar-02-23 07:52AM	Solid Biosciences Inc.'s (NASDAQ:SLDB) 14% loss last week hit both individual investors who own 51% as well as institutions (Simply Wall St.)
Feb-08-23 08:00AM	Solid Biosciences to Present at SVB Securities Global Biopharma Conference (GlobeNewswire) -5.67%
Jan-26-23 08:00AM	Pathway Development Consortium Announces Publication in Human Gene Therapy on the Application of FDAs Accelerated Approval Pathway for AAV Gene Therapies for Patients with Duchenne Muscular Dystrophy (GlobeNewswire)
Jan-11-23 08:00AM	Solid Biosciences and Phlox Therapeutics Announce Strategic Research Collaboration Focused on Accelerating the Development of New Therapies for Rare Cardiac Diseases (GlobeNewswire) +5.04%
Jan-10-23 08:00AM	Solid Biosciences Outlines Strategy for Leadership in Precision Genetic Medicines with Focus on Neuromuscular and Cardiac Diseases (GlobeNewswire)
Jan-09-23 04:26PM	Solid Biosciences Reports Inducement Grant to Chief Financial Officer and Treasurer (GlobeNewswire)
08:01AM	Solid Biosciences Appoints Kevin Tan, CFA, as Chief Financial Officer (GlobeNewswire)
08:00AM	Solid Biosciences to Present at the 41st Annual J.P. Morgan Healthcare Conference (GlobeNewswire)
Dec-05-22 04:35PM	Solid Biosciences Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) (GlobeNewswire)
07:30AM	Solid Biosciences Announces Closing of Acquisition of AavantiBio and Concurrent $75 Million Private Placement (GlobeNewswire)
Dec-01-22 04:15PM	Solid Biosciences Announces Stockholder Approval of Acquisition of AavantiBio (GlobeNewswire)
Nov-22-22 08:00AM	Solid Biosciences to Participate at the Piper Sandler 34th Annual Healthcare Conference (GlobeNewswire)
Nov-10-22 08:55AM	Solid Biosciences Inc. (SLDB) Reports Q3 Loss, Lags Revenue Estimates (Zacks)
07:34AM	Solid Biosciences Provides Third Quarter 2022 Business Update and Financial Results (GlobeNewswire)
Nov-08-22 06:25PM	Adicet Bio, Inc. (ACET) Reports Q3 Loss, Misses Revenue Estimates (Zacks)
Nov-01-22 07:55AM	Techne (TECH) Lags Q1 Earnings and Revenue Estimates (Zacks)
Oct-27-22 10:02AM	Analysts Estimate Albireo Pharma (ALBO) to Report a Decline in Earnings: What to Look Out for (Zacks)
08:00AM	Solid Biosciences Announces a 1-for-15 Reverse Stock Split (GlobeNewswire)
Oct-26-22 10:02AM	Earnings Preview: Solid Biosciences Inc. (SLDB) Q3 Earnings Expected to Decline (Zacks)
Oct-20-22 02:41PM	7 Sizzling Stocks That Are Oblivious to the Manic Market (InvestorPlace)
Oct-17-22 11:30AM	Solid Biosciences Touts Encouraging Preclinical Data From Potential Duchenne Gene Therapy (Benzinga)
08:00AM	Solid Biosciences Reports Additional Preclinical Data Demonstrating that its Novel Capsid, AAV-SLB101, Provides Superior Transduction Efficiency and Enhanced Distribution to Skeletal Muscle (GlobeNewswire)
Oct-13-22 08:00AM	Solid Biosciences Presents New SGT-001 IGNITE DMD Study Results at World Muscle Society 2022 Congress Demonstrating Improvements in Ambulatory Function (GlobeNewswire)
Oct-03-22 05:32AM	Ilan Ganot steps back as CEO from the company he founded to save his son (American City Business Journals) +6.09%
Sep-30-22 07:00AM	Solid Biosciences Announces Acquisition of AavantiBio and Concurrent $75 Million Private Placement (GlobeNewswire)
Sep-29-22 08:00AM	Solid Biosciences to Participate at Upcoming Investor Conferences (GlobeNewswire)
Aug-14-22 08:07AM	Earnings Update: Solid Biosciences Inc. (NASDAQ:SLDB) Just Reported Its Second-Quarter Results And Analysts Are Updating Their Forecasts (Simply Wall St.)
Aug-13-22 08:06AM	Analysts' Revenue Estimates For Solid Biosciences Inc. (NASDAQ:SLDB) Are Surging Higher (Simply Wall St.)
Aug-11-22 09:15AM	Solid Biosciences Inc. (SLDB) Reports Q2 Loss, Tops Revenue Estimates (Zacks)
07:53AM	Solid Biosciences Provides Second Quarter 2022 Business Update and Financial Results (GlobeNewswire)
Jul-14-22 08:13AM	Solid Biosciences (NASDAQ:SLDB) shareholders have endured a 86% loss from investing in the stock three years ago (Simply Wall St.)
Jun-23-22 08:00AM	Solid Biosciences to Present at Upcoming Scientific and Patient Advocacy Conferences (GlobeNewswire) +8.52%
Jun-02-22 08:30AM	Solid Biosciences Reports Inducement Grant to New Senior Vice President, Quality (GlobeNewswire)
08:00AM	Solid Biosciences to Participate at the Jefferies Healthcare Conference (GlobeNewswire)
May-17-22 08:00AM	Solid Biosciences to Present at ASGCT 25th Annual Meeting and CureDuchenne 2022 FUTURES National Conference (GlobeNewswire)
May-02-22 09:29AM	Some Analysts Just Cut Their Solid Biosciences Inc. (NASDAQ:SLDB) Estimates (Simply Wall St.)
Apr-28-22 01:38PM	Duchenne startup lays off 35% of staff, loses COO (American City Business Journals) -8.63%
Apr-27-22 10:35AM	Solid Biosciences Inc. (SLDB) Reports Q1 Loss, Misses Revenue Estimates (Zacks) -16.98%
07:30AM	Solid Biosciences Announces Updated Corporate Strategy to Develop SGT-001 and SGT-003 Pipeline Programs for Patients with Duchenne Muscular Dystrophy (GlobeNewswire)
Apr-25-22 08:00AM	Solid Biosciences Management to Host Call on April 27, 2022 to Discuss Updated Corporate Strategy and First Quarter 2022 Financial Results (GlobeNewswire)
Apr-07-22 08:23AM	Sanofi (SNY) Stock Outperforms Industry YTD: What Lies Ahead? (Zacks) +9.01%
Apr-05-22 02:20PM	Will Solid Biosciences (NASDAQ:SLDB) Spend Its Cash Wisely? (Simply Wall St.)
09:25AM	Alnylam's (ALNY) Vutrisiran NDA Faces Delay in FDA Decision (Zacks)
Apr-04-22 10:40AM	Merck's (MRK) Pneumococcal Vaccine sBLA Faces FDA Delay (Zacks)
Mar-14-22 09:35AM	Solid Biosciences Inc. (SLDB) Reports Q4 Loss, Lags Revenue Estimates (Zacks) -6.10%
08:09AM	Solid Biosciences Reports Fourth Quarter and Full-Year 2021 Financial Results and 2-Year Efficacy and Safety Data from the Ongoing Phase I/II IGNITE DMD Clinical Trial of SGT-001 (GlobeNewswire)
Feb-10-22 08:00AM	Solid Biosciences to Participate at the SVB Leerink 11th Annual Global Healthcare Conference (GlobeNewswire) -6.50%
Feb-04-22 10:14AM	Solid Biosciences (NASDAQ:SLDB) investors are sitting on a loss of 86% if they invested a year ago (Simply Wall St.)
Jan-10-22 08:00AM	Solid Biosciences Outlines its Strategic Priorities for 2022 and Announces Corporate Updates (GlobeNewswire)

Solid Biosciences, Inc. is a life science company, which engages in the development of treatments for patients with Duchenne muscular dystrophy. It also focuses on developing treatments for neuromuscular and cardiac diseases. The company was founded by Ilan Ganot, Andrey J. Zarur, Matthew Bennett Arnold, Annie Ganot, and Gilad David Hayeem in March 2013 and is headquartered in Charlestown, MA.

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
Kahn Clare	Director	Jun 07 '24	Buy	7.67	1,100	8,442	1,100	Jun 11 02:15 PM
Ganot Ilan	Director	May 02 '24	Sale	10.33	462	4,772	9,507	May 06 06:48 PM
Ganot Ilan	Director	Jan 29 '24	Sale	7.99	139	1,111	8,416	Jan 30 05:20 PM
PERCEPTIVE ADVISORS LLC	Director	Jan 11 '24	Buy	5.53	3,410,713	18,861,243	6,833,539	Jan 12 05:15 PM
RA CAPITAL MANAGEMENT, L.P.	Director	Jan 11 '24	Buy	5.53	904,160	5,000,005	4,192,216	Jan 12 05:01 PM
Tan Kevin	CFO & Treasurer	Jan 09 '24	Sale	8.20	3,935	32,267	9,308	Jan 11 05:43 PM
Ganot Ilan	Director	Jan 03 '24	Sale	5.30	1,142	6,052	8,167	Jan 05 07:04 PM
Cumbo Alexander	President and CEO	Dec 04 '23	Sale	2.77	11,757	32,516	17,439	Dec 05 02:40 PM
Howton David T	Chief Operating Officer	Dec 04 '23	Sale	2.78	5,367	14,920	7,684	Dec 05 02:32 PM
Hanrahan Jessie	Chief Regulatory Officer	Dec 04 '23	Sale	2.78	4,879	13,562	6,983	Dec 05 02:30 PM
Marlowe Jennifer	CSO	Dec 04 '23	Sale	2.77	4,890	13,525	6,998	Dec 05 02:30 PM
Herzich Paul	Chief Technology Officer	Dec 04 '23	Sale	2.77	2,968	8,232	4,270	Dec 05 02:31 PM

open in yahoo | open in reuters | open in marketwatch | open in google | open in EDGAR

SLDB

Solid Biosciences Inc

Upgrade your FINVIZ experience